The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
- The FDA issued an emergency use authorization (EUA) for the Philips Medizin Systeme Boeblingen GmbH's IntelliVue Patient Monitors MX750/MX850, IntelliVue 4-Slot Module Rack FMX-4 and IntelliVue Active Displays AD75/AD85, intended to be used by healthcare professionals in the hospital environment for remote monitoring of adult, pediatric and neonate patients having or suspected of having COVID-19 to reduce healthcare provider exposure. The IntelliVue Patient Monitors are not intended for home use. The remote monitoring capabilities of ...
.png)
No hay comentarios:
Publicar un comentario